Nephros Q2 EPS $(0.03) Misses $(0.01) Estimate, Sales $3.25M Miss $3.86M Estimate
Portfolio Pulse from totan@benzinga.com
Nephros (NASDAQ:NEPH) reported Q2 earnings per share (EPS) of $(0.03), missing the analyst consensus estimate of $(0.01) by 200%. Quarterly sales were $3.25 million, missing the $3.86 million estimate by 15.75%. Despite the miss, EPS improved by 25% from the same period last year, while sales decreased by 8.27%.
August 08, 2024 | 8:33 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Nephros reported Q2 EPS of $(0.03), missing the $(0.01) estimate by 200%. Sales of $3.25M missed the $3.86M estimate by 15.75%. EPS improved by 25% YoY, but sales decreased by 8.27%.
The significant miss on both EPS and sales estimates is likely to negatively impact the stock price in the short term. Although EPS improved YoY, the overall financial performance did not meet market expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100